| Hans-Günter Meyer-Thompson | international
Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program.
Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program.
Ward KM, Scheim A, Wang J, Cocchiaro B, Singley K, Roth AM.
Drug Alcohol Depend Rep. 2022 Jun;3:100055. doi: 10.1016/j.dadr.2022.100055. Epub 2022 Apr 26. PMID: 35497489; PMCID: PMC9040407.